866-997-4948(US-Canada Toll Free)

Investigation Report on China Moxifloxacin Market, 2010-2019

Published By :

China Research and Intelligence Co., Ltd. (CRI)

Published Date : Jun 2015

Category :

Manufacturing, Packaging & Detailing

No. of Pages : 20 Pages

As the fourth generation of quinolones drugs, moxifloxacin (moxifloxacin hodrochloride) was first introduced to the market by The Bayer Group in Sep. 1999. It is utilized in the treatment of adult patients (aged 18 and above) diagnosed with upper and lower respiratory tract infections, e.g. acute sinusitis, acute exacerbation of chronic bronchitis (AECB), community-acquired pneumonia, and skin and soft issue infection.

Moxifloxacin was put in the market in Sep. 1999. Having received the approval of American Food and Drug Administration (FDA) on Dec10, 1999, Moxifloxacin entered the US under the trade name of “Avelox”. 

In the second half year of 2002, Moxifloxacin was marketed by The Bayer Group and Beijing Bayer Healthcare Co., Ltd in China. Key markets were major hospitals in large and medium-sized cities in China. Moxifloxacin grew at a rapid pace after entering the Chinese market, with its annual sales value rising from less than CNY 60 million in 2005 to CNY 649 million in 2014 andits CAGR from 2005 to 2014 reaching 30.8%. Moxifloxacin is of great demand in China. Currently, moxifloxacin for sale in China are mainly produced by Nanjing Youke Pharmaceutical CO., Ltd and The Bayer Group whichowns the larger market share of over 95% for sales value in 2014.

As an outstanding antibacterial drug, moxifloxacin is granted with a bright future of application. It is estimated that the moxifloxacin market in China will keep growing in the following few years.

Readers can have access to at least the following information through this report:
  • Market size of Moxifloxacin in China
  • Competitive landscape of Moxifloxacin in the Chinese market
  • prices of Moxifloxacin produced by different enterprises in China
  • market outlook of Moxifloxacin in the Chinese market
The author suggests the following groups of people purchase this report:
  • manufacturers of antibiotic drugs
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service
Table of Content

1 Related Concepts of Moxifloxacin
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Moxifloxacin in China
2.1 Patent and Approval Status of Moxifloxacin in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Moxifloxacin in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Moxifloxacin in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Moxifloxacin in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Moxifloxacin in Chinese Hospitals in 2014
6.1 Nanjing Youke Pharmaceutical Co., Ltd
6.2 The Bayer Group (Germany) (Trade Name: Avelox)

7 Major Manufacturers of Moxifloxacin in Chinese Market, 2010-2014
7.1 Nanjing Youke Pharmaceutical Co., Ltd
7.2 The Bayer Group (Germany)

8 Market Outlook of Moxifloxacin in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Chart


Chart Patent Status of Moxifloxacin in China
Chart Approval Information of Moxifloxacin in China
Chart Sales Status of Moxifloxacin in Chinese Market, 2010-2014
Chart Sales Value of Moxifloxacin in China, 2010-2014
Chart Sales Value of Moxifloxacin in Some Regions of China, 2010-2014
Chart Sales Volume of Moxifloxacin in China, 2010-2014
Chart Sales Volume of Moxifloxacin in Some Regions of China, 2010-2014
Chart Market Share of TOP 2 Manufactures of Moxifloxacin for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Moxifloxacin Produced by Nanjing Youke Pharmaceutical Co., Ltd, 2010-2014
Chart Sales Value and Market Share of Moxifloxacin Produced by The Bayer Group (Germany) in China, 2010-2014
Chart Sales Value and Market Share of Moxifloxacin Injection in China, 2010-2014
Chart Sales Value and Market Share of Moxifloxacin Tablets in China, 2010-2014
Chart Price of Moxifloxacin Produced by Nanjing Youke Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Moxifloxacin Produced by The Bayer Group (Germany) in Some Cities of China in 2014

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *